Shoulder Innovations, Inc.

NYSE:SI

Medical - Specialties

Healthcare
$20.65 -0.72%

-$0.13 today

Market cap
$432.04M
Beta
-1.07
P/E (TTM)
-8.4
EPS (TTM)
-$2.13
52W Low $10.92High $19.79

Volume 0.09M

Average 0.10M

SI Common Stock Repurchased

Cash spent buying back the company's own shares.

Shoulder Innovations, Inc.NYSE: SI

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased outflow grows to $0

Q1 FY2026 common stock repurchased was $0, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was $0.

Context

  • Common stock repurchased amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Common stock repurchased increased in 0 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Common Stock Repurchased vs competitors

How SI compares with its peers on the latest reported figures

  • SI's LTM Mar 2026 common stock repurchased of $0 is the 2nd largest of the 11 companies compared; the peer median is $0.
  • Common stock repurchased amounts to 0.0% of revenue for SI, versus a peer median of 0.0%.
SI Competitors Peer median
Common Stock Repurchased for SI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INGNInogen, Inc.LTM Mar 2026$1.87M +306.5%—0.5%
SIShoulder Innovations, Inc.LTM Mar 2026$0 ——0.0%
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 ———
ASMBAssembly Biosciences, Inc.LTM Mar 2026$0 ——0.0%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 2026$0 ——0.0%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$0 ———
OMOutset Medical, Inc.LTM Mar 2026$0 ——0.0%
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 2026$0 ———
NNOXNano-X Imaging Ltd.LTM Dec 2025$0 ——0.0%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$0 ——0.0%
MDXHMDxHealth S.A.FY2025$0 ——0.0%
Peer median (excluding SI) $0+306.5%—0.0%

Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(12.66M)(15.62M)(40.36M)
Depreciation & Amortization1.64M2.2M3.21M
Deferred Income Tax000
Stock-Based Compensation451K754K996K
Change in Working Capital(4.77M)(1.04M)0
Accounts Receivables(2.69M)(575K)(3.3M)
Inventory(2.41M)(4.03M)(7.64M)
Accounts Payables(737K)3.12M3.37M
Other Working Capital1.08M446K0
Other Non-Cash Items2.18M(437K)7.54M
Operating Cash Flow(13.14M)(14.14M)(28.61M)
Capital Expenditures(2.75M)(4.02M)(7.41M)
Acquisitions (Net)000
Purchases of Investments(29.25M)(5.28M)(119.49M)
Sales of Investments3.03M23.26M31.3M
Other Investing Activities000
Investing Cash Flow(28.97M)13.96M(95.6M)
Debt Repayment10M00
Common Stock Issued34.88M66K39.51M
Common Stock Repurchased000
Dividends Paid000
Other Financing Activities(149K)66K144.96M
Financing Cash Flow44.73M66K144.96M
Effect of Forex Changes000
Net Change in Cash2.61M(113K)20.75M
Free Cash Flow(15.89M)(18.16M)(36.02M)

Shoulder Innovations, Inc.

NYSE:SI

Intrinsic Alpha fair value

Locked

Current Price

$20.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.